IMPACT OF PATIENT FRAILTY ON ONE-YEAR MORTALITY ACROSS CHA2DS2-VASC SCORES: FROM THE TREAT-AF STUDY
2019
The CHA2DS2-VASc score, validated in older and morbid cohorts, guides treatment decisions in patients with atrial fibrillation (AF). We previously found a claims-based frailty phenotype was associated with the CHA2DS2-VASc score and theorize that frailty may be an important driver of outcomes across
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI